Methicillin-Resistant Staphylococcus Aureus (MRSA): Difference between revisions
| Line 18: | Line 18: | ||
###Indicated in severe soft tissue infections and pneumonia thought to be caused by [[CA-MRSA]] or HA-[[MRSA]] | ###Indicated in severe soft tissue infections and pneumonia thought to be caused by [[CA-MRSA]] or HA-[[MRSA]] | ||
==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy | ==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>== | ||
{| class="wikitable" | {| class="wikitable" | ||
| align="center" style="background:#f0f0f0;"|''' | | align="center" style="background:#f0f0f0;"|'''Category''' | ||
| align="center" style="background:#f0f0f0;"|'''''' | | align="center" style="background:#f0f0f0;"|'''Antibiotic''' | ||
| align="center" style="background:#f0f0f0;"|''' | | align="center" style="background:#f0f0f0;"|'''[[MRSA]]''' | ||
|- | |- | ||
| Penicillins||Penicillin G|| | | [[Penicillins]]||[[Penicillin G]]||R | ||
|- | |- | ||
| ||Penicillin V|| | | ||[[Penicillin V]]||R | ||
|- | |- | ||
| | | ||[[Methicillin]]||R | ||
|- | |- | ||
| ||Nafcillin/Oxacillin|| | | ||[[Nafcillin]]/[[Oxacillin]]||R | ||
|- | |- | ||
| ||Cloxacillin/Diclox.|| | | ||[[Cloxacillin]]/[[Diclox.]]||R | ||
|- | |- | ||
| Amino-Penicillins||AMP/Amox|| | | Amino-[[Penicillins]]||[[AMP]]/[[Amox]]||R | ||
|- | |- | ||
| ||Amox | | ||[[Amox-Clav]]||R | ||
|- | |- | ||
| ||AMP-Sulb|| | | ||[[AMP-Sulb]]||R | ||
|- | |- | ||
| Anti-Pseudomonal Penicillins||Ticarcillin|| | | Anti-Pseudomonal [[Penicillins]]||[[Ticarcillin]]||R | ||
|- | |- | ||
| ||Ticar-Clav|| | | ||[[Ticar-Clav]]||R | ||
|- | |- | ||
| ||Pip- | | ||[[Pip-Tazo]]||R | ||
|- | |- | ||
| | | ||Piperacillin||R | ||
|- | |- | ||
| ||Doripenem|| | | [[Carbapenems]]||Doripenem||R | ||
|- | |- | ||
| ||Ertapenem|| | | ||[[Ertapenem]]||R | ||
|- | |- | ||
| ||Imipenem|| | | ||[[Imipenem]]||R | ||
|- | |- | ||
| ||Meropenem|| | | ||[[Meropenem]]||R | ||
|- | |- | ||
| ||[[Aztreonam]]|| | | ||[[Aztreonam]]||R | ||
|- | |- | ||
| [[Fluroquinolones]]||[[Ciprofloxacin]]|| | | [[Fluroquinolones]]||[[Ciprofloxacin]]||R | ||
|- | |- | ||
| ||Ofloxacin|| | | ||[[Ofloxacin]]||R | ||
|- | |- | ||
| ||Pefloxacin|| | | ||Pefloxacin||R | ||
|- | |- | ||
| ||[[Levofloxacin]]|| | | ||[[Levofloxacin]]||R | ||
|- | |- | ||
| ||Moxifloxacin|| | | ||[[Moxifloxacin]]||I | ||
|- | |- | ||
| ||Gemifloxacin|| | | ||Gemifloxacin||I | ||
|- | |- | ||
| ||Gatifloxacin|| | | ||Gatifloxacin||I | ||
|- | |- | ||
| 1st G [[ | | 1st G [[Cephalo]]||Cefazolin||R | ||
|- | |- | ||
| 2nd G. | | 2nd G. [[Cephalo]]||[[Cefotetan]]||R | ||
|- | |- | ||
| ||Cefoxitin|| | | ||[[Cefoxitin]]||R | ||
|- | |- | ||
| ||Cefuroxime|| | | ||[[Cefuroxime]]||R | ||
|- | |- | ||
| 3rd/4th G. | | 3rd/4th G. [[Cephalo]]||[[Cefotaxime]]||R | ||
|- | |- | ||
| ||Cefizoxime|| | | ||Cefizoxime||R | ||
|- | |- | ||
| ||[[CefTRIAXone]]|| | | ||[[CefTRIAXone]]||R | ||
|- | |- | ||
| || | | ||Ceftaroline||S | ||
|- | |- | ||
| || | | ||[[CefTAZidime]]||R | ||
|- | |- | ||
| ||[[ | | ||[[Cefepime]]||R | ||
|- | |- | ||
| | | Oral 1st G. [[Cephalo]]||Cefadroxil||R | ||
|- | |- | ||
| | | ||[[Cephalexin]]||R | ||
|- | |- | ||
| | | Oral 2nd G. [[Cephalo]]||Cefaclor/Loracarbef||R | ||
|- | |- | ||
| | | ||Cefproxil||R | ||
|- | |- | ||
| || | | ||Cefuroxime axetil||R | ||
|- | |- | ||
| || | | Oral 3rd G. [[Cephalo]]||Cefixime||R | ||
|- | |- | ||
| | | ||Ceftibuten||R | ||
|- | |- | ||
| || | | ||Cefpodox/Cefdinir/Cefditoren||R | ||
|- | |- | ||
| || | | [[Aminoglycosides]]||[[Gentamicin]]||R | ||
|- | |- | ||
| | | ||Tobramycin||R | ||
|- | |- | ||
| || | | ||[[Amikacin]]||R | ||
|- | |- | ||
| ||[[ | | ||[[Chloramphenicol]]||R | ||
|- | |- | ||
| || | | ||[[Clindamycin]]||R | ||
|- | |- | ||
| [[Macrolides]]||Erythromycin||R | |||
|- | |- | ||
| [[ | | ||[[Azithromycin]]||R | ||
|- | |- | ||
| || | | ||Clarithromycin||R | ||
|- | |- | ||
| || | | Ketolide||Telithromycin||R | ||
|- | |- | ||
| | | Tetracyclines||[[Doxycycline]]||I | ||
|- | |- | ||
| | | ||Minocycline||I | ||
|- | |- | ||
| || | | Glycylcycline||Tigecycline||S | ||
|- | |- | ||
| | | ||Daptomycin||S | ||
|- | |- | ||
| Glyco/Lipoclycopeptides||[[Vancomycin]]|| | | Glyco/Lipoclycopeptides||[[Vancomycin]]||S | ||
|- | |- | ||
| ||Teicoplanin|| | | ||Teicoplanin||S | ||
|- | |- | ||
| ||Telavancin|| | | ||Telavancin||S | ||
|- | |- | ||
| ||Fusidic Acid|| | | ||Fusidic Acid||S | ||
|- | |- | ||
| ||Trimethoprim|| | | ||Trimethoprim||I | ||
|- | |- | ||
| ||[[TMP-SMX]]|| | | ||[[TMP-SMX]]||S | ||
|- | |- | ||
| Urinary Agents||[[Nitrofurantoin]]|| | | Urinary Agents||[[Nitrofurantoin]]||S | ||
|- | |- | ||
| ||Fosfomycin|| | | ||Fosfomycin||S | ||
|- | |- | ||
| Other||[[Rifampin]]|| | | Other||[[Rifampin]]||S | ||
|- | |- | ||
| ||[[Metronidazole]]|| | | ||[[Metronidazole]]||R | ||
|- | |- | ||
| ||Quinupristin dalfoppristin|| | | ||Quinupristin dalfoppristin||S | ||
|- | |- | ||
| ||Linezolid|| | | ||[[Linezolid]]||S | ||
|- | |- | ||
| ||Colistimethate||R | |||
| ||Colistimethate|| | |||
|} | |} | ||
===Key=== | ===Key=== | ||
{{Template:Antibacterial Spectra Key}} | {{Template:Antibacterial Spectra Key}} | ||
==Prevention== | ==Prevention== | ||
Revision as of 06:40, 3 June 2014
Background
- Two kinds:
- Hospital acquired (MRSA)
- Multi-drug resistant, most commonly seen in ventilator associated pneumonia, post operative infections, and catheter associated infections
- Community acquired (see CA-MRSA)
- Tends to be resistant to beta-lactams, most commonly seen in Skin and Soft Tissue Infections and rarely in necrotizing pneumonia
- Hospital acquired (MRSA)
Risk Factors
- multiple skin sites
- recurrent infection
- pt who has been in close contact of person with Hx of MRSA
- infection showing early necrosis
Treatment
- Antibiotics
- Vancomycin IV if severe infection/sepsis
- Linezolid
Antibiotic Sensitivities[1]
| Category | Antibiotic | MRSA |
| Penicillins | Penicillin G | R |
| Penicillin V | R | |
| Methicillin | R | |
| Nafcillin/Oxacillin | R | |
| Cloxacillin/Diclox. | R | |
| Amino-Penicillins | AMP/Amox | R |
| Amox-Clav | R | |
| AMP-Sulb | R | |
| Anti-Pseudomonal Penicillins | Ticarcillin | R |
| Ticar-Clav | R | |
| Pip-Tazo | R | |
| Piperacillin | R | |
| Carbapenems | Doripenem | R |
| Ertapenem | R | |
| Imipenem | R | |
| Meropenem | R | |
| Aztreonam | R | |
| Fluroquinolones | Ciprofloxacin | R |
| Ofloxacin | R | |
| Pefloxacin | R | |
| Levofloxacin | R | |
| Moxifloxacin | I | |
| Gemifloxacin | I | |
| Gatifloxacin | I | |
| 1st G Cephalo | Cefazolin | R |
| 2nd G. Cephalo | Cefotetan | R |
| Cefoxitin | R | |
| Cefuroxime | R | |
| 3rd/4th G. Cephalo | Cefotaxime | R |
| Cefizoxime | R | |
| CefTRIAXone | R | |
| Ceftaroline | S | |
| CefTAZidime | R | |
| Cefepime | R | |
| Oral 1st G. Cephalo | Cefadroxil | R |
| Cephalexin | R | |
| Oral 2nd G. Cephalo | Cefaclor/Loracarbef | R |
| Cefproxil | R | |
| Cefuroxime axetil | R | |
| Oral 3rd G. Cephalo | Cefixime | R |
| Ceftibuten | R | |
| Cefpodox/Cefdinir/Cefditoren | R | |
| Aminoglycosides | Gentamicin | R |
| Tobramycin | R | |
| Amikacin | R | |
| Chloramphenicol | R | |
| Clindamycin | R | |
| Macrolides | Erythromycin | R |
| Azithromycin | R | |
| Clarithromycin | R | |
| Ketolide | Telithromycin | R |
| Tetracyclines | Doxycycline | I |
| Minocycline | I | |
| Glycylcycline | Tigecycline | S |
| Daptomycin | S | |
| Glyco/Lipoclycopeptides | Vancomycin | S |
| Teicoplanin | S | |
| Telavancin | S | |
| Fusidic Acid | S | |
| Trimethoprim | I | |
| TMP-SMX | S | |
| Urinary Agents | Nitrofurantoin | S |
| Fosfomycin | S | |
| Other | Rifampin | S |
| Metronidazole | R | |
| Quinupristin dalfoppristin | S | |
| Linezolid | S | |
| Colistimethate | R |
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
Prevention
- good hand hygiene
- avoid sharing personal items with carriers
- wash common household items with bleach and hot water
- wash soiled sheets, towels, clothes in hot water with bleach and dry in hot dryer
- Eradicate carriers:
- mupirocin 2%: apply to each nostril TID x 5days
- Hibiclens wash daily x 5 days
- consider oral antibiotics
Table Overview
| ||||||||||||||||||||||||||||||||||||||||
See Also
Source
- EBmedicine.net
References
- ↑ Sanford Guide to Antimicrobial Therapy 2014
